Literature DB >> 19558509

The inhibitory effect of resveratrol on leptin secretion from rat adipocytes.

K Szkudelska1, L Nogowski, T Szkudelski.   

Abstract

BACKGROUND: Resveratrol was found to alleviate consequences of some metabolic disturbances which may be due to inappropriate dietary habits. It decreases mortality, increases insulin sensitivity and improves motor functions; these effects are accompanied by reduced plasma leptin and insulin. Leptin plays a significant role in the regulation of food intake and energy expenditure - elevated level in blood is one of the reasons of leptin-resistance and obesity. In this study, the direct effect of resveratrol on leptin secretion from isolated adipocytes was investigated.
MATERIAL AND METHODS: Isolated rat adipocytes were incubated with resveratrol (62.5, 125 or 250 microM) and its effects on leptin secretion were studied. Cells were incubated with resveratrol in the presence of glucose (5 and 20 mM) and insulin (10 nM); glucose and nicotinic acid (1 mM); glucose and insulin in the presence of an inhibitor of protein kinase A (H-89, 50 microM) or alanine (10 mM) and insulin. The glucose uptake, glycerol release to the incubation medium, lactate and ATP produced by the cells were also measured.
RESULTS: Resveratrol inhibited leptin secretion in all experimental designs in a dose-dependent manner. The effect was not accompanied by changes in glycerol release and glucose uptake. Adipocyte exposure to resveratrol enhanced the lactate formation. It was found that resveratrol dramatically reduced ATP in adipocytes.
CONCLUSION: The obtained results revealed the direct ability of resveratrol to reduce leptin secretion from isolated rat adipocytes. Resveratrol is therefore a compound affecting the endocrine function of adipocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19558509     DOI: 10.1111/j.1365-2362.2009.02188.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  8 in total

Review 1.  G protein-coupled receptors and adipogenesis: a focus on adenosine receptors.

Authors:  Anna Eisenstein; Katya Ravid
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

2.  Resveratrol treatment rescues hyperleptinemia and improves hypothalamic leptin signaling programmed by maternal high-fat diet in rats.

Authors:  J G Franco; C P Dias-Rocha; T P Fernandes; L Albuquerque Maia; P C Lisboa; E G Moura; C C Pazos-Moura; I H Trevenzoli
Journal:  Eur J Nutr       Date:  2015-03-24       Impact factor: 5.614

3.  Proliferative endocrine effects of adipose tissue from obese animals on MCF7 cells are ameliorated by resveratrol supplementation.

Authors:  Christopher F Theriau; O'Llenecia S Sauvé; Marie-Soleil Beaudoin; David C Wright; Michael K Connor
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

Review 4.  COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.

Authors:  Larissa E van Eijk; Mathijs Binkhorst; Arno R Bourgonje; Annette K Offringa; Douwe J Mulder; Eelke M Bos; Nikola Kolundzic; Amaal E Abdulle; Peter Hj van der Voort; Marcel Gm Olde Rikkert; Johannes G van der Hoeven; Wilfred Fa den Dunnen; Jan-Luuk Hillebrands; Harry van Goor
Journal:  J Pathol       Date:  2021-03-25       Impact factor: 9.883

5.  Resveratrol metabolites modify adipokine expression and secretion in 3T3-L1 pre-adipocytes and mature adipocytes.

Authors:  Itziar Eseberri; Arrate Lasa; Itziar Churruca; María P Portillo
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

6.  Peanut sprouts extract (Arachis hypogaea L.) has anti-obesity effects by controlling the protein expressions of PPARγ and adiponectin of adipose tissue in rats fed high-fat diet.

Authors:  Nam E Kang; Ae Wha Ha; Hye Won Woo; Woo Kyoung Kim
Journal:  Nutr Res Pract       Date:  2014-03-28       Impact factor: 1.926

7.  Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue.

Authors:  Peter H J van der Voort; Jill Moser; Durk F Zandstra; Anneke C Muller Kobold; Marjolein Knoester; Cornelis F Calkhoven; Inge Hamming; Matijs van Meurs
Journal:  Heliyon       Date:  2020-08-20

Review 8.  Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).

Authors:  Arno R Bourgonje; Amaal E Abdulle; Wim Timens; Jan-Luuk Hillebrands; Gerjan J Navis; Sanne J Gordijn; Marieke C Bolling; Gerard Dijkstra; Adriaan A Voors; Albert Dme Osterhaus; Peter Hj van der Voort; Douwe J Mulder; Harry van Goor
Journal:  J Pathol       Date:  2020-06-10       Impact factor: 9.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.